375 related articles for article (PubMed ID: 17020974)
21. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
[TBL] [Abstract][Full Text] [Related]
22. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy.
Yang Q; Moran MS; Haffty BG
Breast Cancer Res Treat; 2009 May; 115(2):343-8. PubMed ID: 18516673
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic molecular classification of breast cancers based on gene expression profiling].
Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
[TBL] [Abstract][Full Text] [Related]
25. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma.
Kroman N; Holtveg H; Wohlfahrt J; Jensen MB; Mouridsen HT; Blichert-Toft M; Melbye M
Cancer; 2004 Feb; 100(4):688-93. PubMed ID: 14770422
[TBL] [Abstract][Full Text] [Related]
26. Search for a gene expression signature of breast cancer local recurrence in young women.
Servant N; Bollet MA; Halfwerk H; Bleakley K; Kreike B; Jacob L; Sie D; Kerkhoven RM; Hupé P; Hadhri R; Fourquet A; Bartelink H; Barillot E; Sigal-Zafrani B; van de Vijver MJ
Clin Cancer Res; 2012 Mar; 18(6):1704-15. PubMed ID: 22271875
[TBL] [Abstract][Full Text] [Related]
27. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
28. Selecting patients for breast-conserving therapy: the importance of lobular histology.
Morrow M; Keeney K; Scholtens D; Wei J; Steel J; Khan SA
Cancer; 2006 Jun; 106(12):2563-8. PubMed ID: 16683225
[TBL] [Abstract][Full Text] [Related]
29. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
[TBL] [Abstract][Full Text] [Related]
30. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
Jolly S; Kestin LL; Goldstein NS; Vicini FA
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
[TBL] [Abstract][Full Text] [Related]
31. Radiation-associated breast tumors display a distinct gene expression profile.
Broeks A; Braaf LM; Wessels LF; van de Vijver M; De Bruin ML; Stovall M; Russell NS; van Leeuwen FE; Van 't Veer LJ
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):540-7. PubMed ID: 20117289
[TBL] [Abstract][Full Text] [Related]
32. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.
Harris EE; Hwang WT; Lee EA; Cengel KA; Feldman MD; Demichele A; Kao G; Solin LJ
Breast J; 2006; 12(5):431-6. PubMed ID: 16958961
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
[TBL] [Abstract][Full Text] [Related]
34. The effect of timing of radiotherapy after breast-conserving surgery in patients with positive or close resection margins, young age, and node-negative disease, with long term follow-up.
Vujovic O; Cherian A; Yu E; Dar AR; Stitt L; Perera F
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):687-90. PubMed ID: 16949764
[TBL] [Abstract][Full Text] [Related]
35. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
36. Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer.
Indelicato D; Grobmyer SR; Newlin H; Morris CG; Haigh LS; Copeland EM; Mendenhall NP
Surgery; 2007 May; 141(5):645-53. PubMed ID: 17462465
[TBL] [Abstract][Full Text] [Related]
37. The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery.
O'Sullivan MJ; Li T; Freedman G; Morrow M
Ann Surg Oncol; 2007 Nov; 14(11):3133-40. PubMed ID: 17653798
[TBL] [Abstract][Full Text] [Related]
38. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
39. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
[TBL] [Abstract][Full Text] [Related]
40. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling.
Van Laere SJ; Van den Eynden GG; Van der Auwera I; Vandenberghe M; van Dam P; Van Marck EA; van Golen KL; Vermeulen PB; Dirix LY
Breast Cancer Res Treat; 2006 Feb; 95(3):243-55. PubMed ID: 16261404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
